enow.com Web Search

  1. Ads

    related to: short acting insulin brands

Search results

  1. Results from the WOW.Com Content Network
  2. Regular insulin - Wikipedia

    en.wikipedia.org/wiki/Regular_insulin

    Regular insulin, also known as neutral insulin and soluble insulin, is a type of short-acting medical insulin. [2] It is used to treat type 1 diabetes , type 2 diabetes , gestational diabetes , and complications of diabetes such as diabetic ketoacidosis and hyperosmolar hyperglycemic states . [ 5 ]

  3. Insulin (medication) - Wikipedia

    en.wikipedia.org/wiki/Insulin_(medication)

    People with insulin-dependent diabetes typically require some base level of insulin (basal insulin), as well as short-acting insulin to cover meals (bolus also known as mealtime or prandial insulin). Maintaining the basal rate and the bolus rate is a continuous balancing act that people with insulin-dependent diabetes must manage each day.

  4. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Meglitinides help the pancreas produce insulin and are often called "short-acting secretagogues." They act on the same potassium channels as sulfonylureas, but at a different binding site. [ 29 ] By closing the potassium channels of the pancreatic beta cells, they open the calcium channels, thereby enhancing insulin secretion.

  5. Health Rounds: Once-weekly insulin from Eli Lilly appears ...

    www.aol.com/news/health-rounds-once-weekly...

    Everyone with type 1 diabetes in the trial also used a short-acting insulin at mealtimes. In July, Lilly rival Novo Nordisk failed to secure U.S. approval for its own once-weekly basal insulin ...

  6. Insulin lispro - Wikipedia

    en.wikipedia.org/wiki/Insulin_lispro

    Insulin lispro, sold under the brand name Humalog among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [5] It is delivered subcutaneously either by injection or from an insulin pump .

  7. Insulin analog - Wikipedia

    en.wikipedia.org/wiki/Insulin_analog

    This is an ultralong-acting insulin analogue developed by Novo Nordisk, which markets it under the brand name Tresiba. It is administered once daily and has a duration of action that lasts up to 40 hours (compared to 18 to 26 hours provided by other marketed long-acting insulins such as insulin glargine and insulin detemir). [5] [6]

  1. Ads

    related to: short acting insulin brands